Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

SARmont LLC
Profile last edited on: 3/17/2014      CAGE: 65WN5      UEI: NCRNKTEUXVF3

Business Identifier: Identifies proprietary drug candidates and helps to develop IP strategy
Year Founded
2010
First Award
2011
Latest Award
2011
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

4320 Forest Park Avenue Suite 303
Saint Louis, MO 63108
   (314) 932-4032
   rweiss@sarmont.com
   www.sarmont.com
Location: Single
Congr. District: 01
County: St. Louis city

Public Profile

SARmont, LLC provides contract medicinal chemistry design and lead optimization services to pharmaceutical companies and research institutions. The company identifies proprietary drug candidates and helps to develop IP strategy for its client companies. Its services include consulting service to support the early analysis of potential assets for academic or early stage ventures; and project management and virtual outsourcing.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$161,500
Phase II Dollars
$0
Total Awarded
$161,500

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2011 1 NIH $161,500
Project Title: Controlled Release of Topical Nitric Oxide for Treating Cutaneous Injuries

Key People / Management

  Randy H Weiss -- President & CEO

  Rick Ryan -- Vice President Business Development

  John J Talley -- Chief Scientific Officer

Company News

There are no news available.